QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 amgenastrazeneca-say-asthma-drug-shows-activity-in-another-lung-disease-across-broad-patient-population

Amgen and AstraZeneca reveal Phase 2a results for Tezspire in severe COPD, showing a 17% reduction in exacerbations, with notab...

 pfizer-wins-1075m-verdict-against-astrazeneca-over-cancer-drug-patent-dispute

A Delaware jury ordered AstraZeneca to pay Pfizer $107.5 million, ruling that AstraZeneca's lung cancer drug Tagrisso infri...

Core News & Articles

Late-breaking results from the Phase IIa COURSE trial provide insight into TEZSPIRE's impact on COPD exacerbations in patie...

Core News & Articles

- Reuters

 astrazenecas-covid-19-prevention-therapy-cuts-risk-of-infection-in-patients-with-weaker-immunity-data-shows

AstraZeneca's Phase 3 SUPERNOVA trial shows sipavibart significantly reduces symptomatic COVID-19 in immunocompromised pati...

 pfizer-astrazeneca-sanofi-and-mainz-biomed-to-uplevel-europes-pharma-game

On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will...

 healthcare-giants-pfizer-astrazeneca-sanofi-inject-over-2b-to-boost-frances-healthcare-sector

Pfizer and AstraZeneca invest over $1 billion in France's healthcare sector, bolstering R&D capabilities and job creation.

 elon-musk-breaks-ranks-with-gop-by-praising-genetic-engineering-tech-that-helped-fight-covid-19-digital-medicine-with-incredible-potential

Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists.

 astrazeneca-pulls-plug-on-vaxzevria-covid-19-vaccine-amid-surplus-of-updated-vaccines

It is worth noting that AstraZeneca has previously conceded in court documents that Vaxzevria can induce side effects such as b...

 astrazeneca-withdrawing-its-covid-vaccine-worldwide

https://www.telegraph.co.uk/news/2024/05/07/astrazeneca-withdrawing-covid-vaccine/

Core News & Articles

As part of the Additional Investment, AstraZeneca subscribed today for 10,000,000 "class A" convertible preferred share...

Core News & Articles

Under the terms of this agreement, worth £550,000 to ANGLE, the Company will develop a CTC-based AR assay. Assay development wi...

Core News & Articles

New real-world evidence shows Beyfortus (nirsevimab) substantially reduced RSV lower respiratory tract disease and hospitaliz...

 federal-trade-commission-targets-junk-patent-listings-for-diabetes-weight-loss-asthma-drugs-from-companies-like-novo-nordisk-astrazeneca

The FTC intensifies efforts against pharmaceutical patent listings, disputing junk patents for diabetes, weight loss, asthma, a...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION